CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?
Author
A Grothey
A Lievre
+29 more
Abdullah Sakin
AK Patel
AP Venook
Aysun Fatma Doğan
BJ Giantonio
Bülent Erdoğan
C Matsuda
D Arnold
EA Eisenhauer
FO Larsen
HC Kwon
İrfan Çiçin
J Li
JT Hartmann
M Chaix
M Suenaga
M Yoshida
MA Shah
Muhammet Bekir Hacıoğlu
Murat Araz
Murat Sarı
Nazım Can Demircan
Osman Köstek
Ozlem Ozkul
P Jime´nez-Fonseca
Sernaz Uzunoğlu
Tarık Demir
V Gebbia
V Heinemann
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref